Loading ETF profile…
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 11.39% | $1.07M |
| LH | Labcorp Holdings Inc | 7.20% | $674.40K |
| DGX | Quest Diagnostics Inc | 6.61% | $618.44K |
| BNTX | BioNTech SE | 5.01% | $468.88K |
| BIO | Bio-Rad Laboratories Inc | 4.74% | $443.37K |
| PCVX | Vaxcyte Inc | 4.52% | $423.10K |
| QDEL | QuidelOrtho Corp | 4.11% | $384.99K |
| BCRX | BioCryst Pharmaceuticals Inc | 3.70% | $346.60K |
| IMCR | Immunocore Holdings PLC | 3.67% | $343.21K |
| ZLAB | Zai Lab Ltd | 3.60% | $337.05K |
| MRNA | Moderna Inc | 3.46% | $324.35K |
| DVAX | Dynavax Technologies Corp | 3.42% | $319.80K |
| IBRX | ImmunityBio Inc | 3.14% | $293.61K |
| VIR | Vir Biotechnology Inc | 2.79% | $260.85K |
| NVAX | Novavax Inc | 2.50% | $233.64K |
| OPK | OPKO Health Inc | 2.46% | $230.12K |
| CVAC | CureVac NV | 1.73% | $161.94K |
| FLGT | Fulgent Genetics Inc | 1.68% | $157.56K |
| ABUS | Arbutus Biopharma Corp | 1.62% | $151.62K |
| ADPT | Adaptive Biotechnologies Corp | 1.55% | $145.00K |
| SIGA | SIGA Technologies Inc | 1.45% | $136.04K |
| ARCT | Arcturus Therapeutics Holdings Inc | 1.14% | $107.18K |
| GILD | Gilead Sciences Inc | 1.01% | $94.65K |
| REGN | Regeneron Pharmaceuticals Inc | 0.99% | $92.76K |
| ABBV | AbbVie Inc | 0.98% | $91.93K |